Alvotech and JAMP Pharma add two biosimilar candidates for Canadian market
Alvotech and the JAMP Pharma Group have expanded their exclusive partnership to commercialize biosimilars developed…
Alvotech and the JAMP Pharma Group have expanded their exclusive partnership to commercialize biosimilars developed…
The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) has received a major grant from the…
AbbVie’s Humira, a treatment for inflammatory disease and the world’s best-selling drug, is no longer…
Cyltezo, an adalimumab biosimilar drug by Boehringer Ingelheim, has received the backing to be marketed…
Samsung Bioepis has announced the European Commission approved Imraldi, a biosimilar of AbbVie's Humira (adalimumab),…
Despite bringing a significant price reduction, biosimilars might lag in taking over the market of…
The European Commission has approved Truxima, the world's first biosimilar monoclonal antibody (mAb) with an…
The new guidelines from the FDA on interchangeability may bring the US biosimilar market up…
Sanofi is joining the biosimilars trend to challenge Roche's best-selling biological with a partnership that…
Boehringer Ingelheim is getting ready to launch a biosimilar for Roche's cancer blockbuster Avastin as…
As legal frameworks and regulatory pathways for biosimilars are in evolving all around the world,…
Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a…